IL218948A0 - Use of rasagiline for the treatment of progressive supranuclear palsy - Google Patents
Use of rasagiline for the treatment of progressive supranuclear palsyInfo
- Publication number
- IL218948A0 IL218948A0 IL218948A IL21894812A IL218948A0 IL 218948 A0 IL218948 A0 IL 218948A0 IL 218948 A IL218948 A IL 218948A IL 21894812 A IL21894812 A IL 21894812A IL 218948 A0 IL218948 A0 IL 218948A0
- Authority
- IL
- Israel
- Prior art keywords
- rasagiline
- treatment
- progressive supranuclear
- supranuclear palsy
- palsy
- Prior art date
Links
- 201000002212 progressive supranuclear palsy Diseases 0.000 title 1
- RUOKEQAAGRXIBM-GFCCVEGCSA-N rasagiline Chemical compound C1=CC=C2[C@H](NCC#C)CCC2=C1 RUOKEQAAGRXIBM-GFCCVEGCSA-N 0.000 title 1
- 229960000245 rasagiline Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Nutrition Science (AREA)
- Ophthalmology & Optometry (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Pulmonology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US27867709P | 2009-10-09 | 2009-10-09 | |
| PCT/IB2010/002852 WO2011042812A1 (en) | 2009-10-09 | 2010-10-08 | Use of rasagiline for the treatment of progressive supranuclear palsy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL218948A0 true IL218948A0 (en) | 2012-07-31 |
Family
ID=43533485
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL218948A IL218948A0 (en) | 2009-10-09 | 2012-03-29 | Use of rasagiline for the treatment of progressive supranuclear palsy |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20110130466A1 (enExample) |
| EP (1) | EP2485722A1 (enExample) |
| JP (1) | JP2013507352A (enExample) |
| AU (1) | AU2010304755A1 (enExample) |
| CA (1) | CA2777185A1 (enExample) |
| IL (1) | IL218948A0 (enExample) |
| WO (1) | WO2011042812A1 (enExample) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA200704917B (en) * | 2004-11-24 | 2008-11-26 | Teva Pharma | Rasagiline orally disintegrating compositions |
| JP5701485B2 (ja) * | 2006-02-21 | 2015-04-15 | テバ ファーマシューティカル インダストリーズ リミティド | 多系統萎縮症の治療のためのラサギリンの使用 |
| WO2007117431A2 (en) | 2006-04-03 | 2007-10-18 | Teva Pharmaceutical Industries, Ltd. | Use of rasagiline for the treatment of restless legs syndrome |
| EP1892233A1 (de) | 2006-08-18 | 2008-02-27 | Ratiopharm GmbH | Neue Salze des Wirkstoffs Rasagilin |
| CN101557706B (zh) * | 2006-12-14 | 2013-08-07 | 泰华制药工业有限公司 | 雷沙吉兰碱结晶固体 |
| EP1987816A1 (de) * | 2007-04-30 | 2008-11-05 | Ratiopharm GmbH | Adsorbate eines Rasagilinsalzes mit einem wasserlöslichen Hilfsstoff |
| JP2010538067A (ja) * | 2007-09-05 | 2010-12-09 | テバ ファーマシューティカル インダストリーズ リミティド | ラサギリンを使用する緑内障の治療方法 |
| MX2010007601A (es) * | 2008-01-11 | 2010-08-03 | Teva Pharma | Formulaciones de rasagilina, su preparacion y uso. |
| JP2011524353A (ja) * | 2008-06-10 | 2011-09-01 | テバ ファーマシューティカル インダストリーズ リミティド | ラサギリン軟ゼラチンカプセル |
| EA201170018A1 (ru) * | 2008-06-13 | 2011-08-30 | Тева Фармасьютикал Индастриз, Лтд. | Разагилин для изменения течения болезни паркинсона |
| CN102065853A (zh) * | 2008-06-19 | 2011-05-18 | 泰华制药工业有限公司 | 制备和干燥固体雷沙吉兰碱的方法 |
| EP2299993A4 (en) * | 2008-06-19 | 2014-08-20 | Teva Pharma | PROCESS FOR PURIFYING THE BASE OF RASAGILINE |
| US8080584B2 (en) | 2009-01-23 | 2011-12-20 | Teva Pharmaceuticals Industries, Ltd. | Delayed release rasagiline citrate formulation |
| CA2767592A1 (en) | 2009-07-09 | 2011-01-13 | Ratiopharm Gmbh | Salts of rasagiline and pharmaceutical preparations thereof |
| EP2939669A1 (en) * | 2009-12-22 | 2015-11-04 | Teva Pharmaceutical Industries, Ltd. | 3-keto-n-propargyl-1-aminoindan |
| RU2013108256A (ru) | 2010-07-27 | 2014-09-10 | Тева Фармасьютикал Индастриз Лтд. | Дисперсии цитрата разагилина |
| AU2011282720B2 (en) | 2010-07-27 | 2016-12-22 | Teva Pharmaceutical Industries Ltd. | Use of rasagiline for the treatment of olfactory dysfunction |
| HK1200315A1 (en) | 2011-10-10 | 2015-08-07 | Teva Pharmaceutical Industries Ltd. | R(+)-n-formyl-propargyl-aminoindan |
| AU2012323351A1 (en) | 2011-10-10 | 2014-05-22 | Teva Pharmaceutical Industries Ltd. | R(+)-N-methyl-propargyl-aminoindan |
| JP2015529196A (ja) | 2012-08-17 | 2015-10-05 | テバ ファーマシューティカル インダストリーズ リミティド | ラサギリンの非経口製剤 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA200704917B (en) * | 2004-11-24 | 2008-11-26 | Teva Pharma | Rasagiline orally disintegrating compositions |
| EP2004204B1 (en) * | 2006-03-29 | 2012-09-12 | Velacor Therapeutics Pty Ltd | Treatment of neurodegenerative diseases with selenate |
| EP1892233A1 (de) * | 2006-08-18 | 2008-02-27 | Ratiopharm GmbH | Neue Salze des Wirkstoffs Rasagilin |
| WO2009054544A1 (en) * | 2007-10-26 | 2009-04-30 | Eisai R & D Management Co., Ltd. | Ampa receptor antagonists for parkinson's disease and movement disorders |
| EP2299993A4 (en) * | 2008-06-19 | 2014-08-20 | Teva Pharma | PROCESS FOR PURIFYING THE BASE OF RASAGILINE |
| CN102065853A (zh) * | 2008-06-19 | 2011-05-18 | 泰华制药工业有限公司 | 制备和干燥固体雷沙吉兰碱的方法 |
| DE102008064061A1 (de) * | 2008-12-19 | 2010-06-24 | Ratiopharm Gmbh | Feste Zusammensetzung mit dem Wirkstoff Rasagilin |
| US8080584B2 (en) * | 2009-01-23 | 2011-12-20 | Teva Pharmaceuticals Industries, Ltd. | Delayed release rasagiline citrate formulation |
| RU2013108256A (ru) * | 2010-07-27 | 2014-09-10 | Тева Фармасьютикал Индастриз Лтд. | Дисперсии цитрата разагилина |
| AU2011282720B2 (en) * | 2010-07-27 | 2016-12-22 | Teva Pharmaceutical Industries Ltd. | Use of rasagiline for the treatment of olfactory dysfunction |
| MX2013004598A (es) * | 2010-10-26 | 2013-07-17 | Teva Pharma | Rasagilina enriquesida con deuterio. |
| US20130089611A1 (en) * | 2011-10-10 | 2013-04-11 | Teva Pharmaceutical Industries, Ltd. | Rasagiline citramide |
| HK1200315A1 (en) * | 2011-10-10 | 2015-08-07 | Teva Pharmaceutical Industries Ltd. | R(+)-n-formyl-propargyl-aminoindan |
| AU2012323351A1 (en) * | 2011-10-10 | 2014-05-22 | Teva Pharmaceutical Industries Ltd. | R(+)-N-methyl-propargyl-aminoindan |
-
2010
- 2010-10-08 WO PCT/IB2010/002852 patent/WO2011042812A1/en not_active Ceased
- 2010-10-08 AU AU2010304755A patent/AU2010304755A1/en not_active Abandoned
- 2010-10-08 US US12/901,281 patent/US20110130466A1/en not_active Abandoned
- 2010-10-08 JP JP2012532683A patent/JP2013507352A/ja active Pending
- 2010-10-08 CA CA2777185A patent/CA2777185A1/en not_active Abandoned
- 2010-10-08 EP EP10785198A patent/EP2485722A1/en not_active Withdrawn
-
2012
- 2012-03-29 IL IL218948A patent/IL218948A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2010304755A1 (en) | 2012-05-24 |
| EP2485722A1 (en) | 2012-08-15 |
| US20110130466A1 (en) | 2011-06-02 |
| CA2777185A1 (en) | 2011-04-14 |
| JP2013507352A (ja) | 2013-03-04 |
| WO2011042812A1 (en) | 2011-04-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL218948A0 (en) | Use of rasagiline for the treatment of progressive supranuclear palsy | |
| ZA201209725B (en) | Composition for improving sexual wellness | |
| GB0921731D0 (en) | Theraputic uses | |
| ZA201202504B (en) | Process for the preparation of calcobutrol | |
| PT2362764T (pt) | Dispositivo de mobilização corporal e utilização desse dispositivo | |
| AU329518S (en) | Massage apparatus | |
| EP2436359A4 (en) | GODEMICHÉ FOR SEXUAL STIMULATION | |
| GB2482817B (en) | Novel use | |
| PL390042A1 (pl) | Sposób wytwarzania kwasu chlebowego | |
| EP2440216A4 (en) | USE OF A COMPOSITION FOR TREATING MUCOSITIS | |
| PL388931A1 (pl) | Sposób otrzymywania fluorokarbofunkcyjnych silseskwioksanów | |
| ZA201107111B (en) | Process for the preparation of layered silicates | |
| GB0905189D0 (en) | Improvements relating to crutches | |
| GB0905864D0 (en) | Novel use | |
| GB0916744D0 (en) | Crutch aid | |
| SI2430078T1 (sl) | Postopek za pripravo sevelamerja | |
| PL2536398T3 (pl) | Leczenie osteoporozy | |
| TWM365740U (en) | Massager structure | |
| PL389594A1 (pl) | Sposób wytwarzania sulfidów fluorohalogenometyloarylowych | |
| TWM365741U (en) | Tepid massager | |
| TWI365054B (en) | Crutch structure | |
| TWM372715U (en) | Sound-controlled massager | |
| HU0900505D0 (en) | Sexual stimulation devices | |
| TWM365745U (en) | Adjustable crutch | |
| GB0918382D0 (en) | Osteoporosis treatment |